HOME >> BIOLOGY >> NEWS
'Radical' discovery dedicated a National Historic Chemical Landmark

Immigrant chemist's revolutionary finding advances medicine and plastics

University of Michigan chemist Moses Gomberg's discovery of organic free radicals will be designated a National Historic Chemical Landmark by the American Chemical Society, the world's largest scientific society, on June 25 at the university's Ann Arbor campus. When Gomberg announced in 1900 that he had isolated an organic free radical - a carbon molecule with an odd number of electrons - the chemistry establishment greeted the news with skepticism, then dismissed it as a curiosity. A century later, Gomberg's breakthrough has led to profound advances in biochemistry, biology and medicine, as well as the production of plastics for everything from children's toys to the space shuttle.

The American Chemical Society National Historic Chemical Landmarks program commemorates and preserves landmarks in the history of chemistry, and heightens public awareness of the key role chemistry has played in the history of the United States and nations around the world.

WHO: Dr. Daryle Busch, ACS President
University of Kansas

WHAT: Designation of Moses Gomberg's discovery of organic free radicals as a National Historic Chemical Landmark

WHEN: 5:15 p.m., Sunday, June 25, 2000

WHERE: University of Michigan central campus
1800 Chemistry Building
930 North University Street
Ann Arbor, Mich.


'"/>

Contact: Hillarie Fogel
h_fogel@acs.org
202-872-4371
American Chemical Society
7-Jun-2000


Page: 1

Related biology news :

1. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
2. New OHSU lab will speed drug discovery process
3. New discovery may help transplants survive
4. Genetic discovery could dramatically reduce need for liver transplants in children
5. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
6. Major scientific discovery in cancer research to be honored
7. New discovery could provide tool to detect whether a cancer will develop and spread
8. UNC research accelerates discovery of novel gene function
9. Tulane opens doors to discovery
10. U. Iowa muscular dystrophy discovery may lead to new treatment approaches
11. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... FRANCISCO (PRWEB) , ... February 04, 2019 , ... ... of a new Explorer™ story which provides insights to help individuals understand how ... to decreased cardiovascular wellness. , After individuals eat foods that contain choline ...
(Date:2/2/2019)... ... February 01, 2019 , ... uBiome, ... Testing Laboratories by A2LA, which establishes requirements for medical laboratories to demonstrate competence ... is already CLIA-licensed as well as College of American Pathologists (CAP)-accredited, a designation ...
(Date:1/24/2019)... ... 23, 2019 , ... rHEALTH LLC, an innovative digital health ... the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. ... This application covers the addition of a length scale to hydrogel microparticles. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 15, 2019 , ... Personalized treatment plans may extend life expectancy for early-stage ... new study published in the journal Radiology. , Kidney, or renal, tumors are ... surgical procedure in which the tumor and part of the kidney are removed. However, ...
(Date:1/11/2019)... ... 11, 2019 , ... Drawing on over 22 years of software development expertise, ... EST will explore some of the key lessons that have driven customer satisfaction with ... multiple vendors, and find out how to ensure that you continue to be able ...
(Date:1/10/2019)... (PRWEB) , ... January 08, 2019 , ... VGI Medical ... has become a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin ... the facet joint by utilizing a unique patented dual geometric design to limit motion ...
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
Breaking Biology Technology:
Cached News: